The World Congress of Pediatric Dermatology: Key Sessions and Takeaways

Authors

  • Cathryn Sibbald, MSc, MD, FRCPC, DABD Division of Dermatology, Department of Paediatrics The Hospital for Sick Children, Toronto, ON, University of Toronto, Toronto, ON

DOI:

https://doi.org/10.58931/cdt.2025.62141

Abstract

The World Congress of Pediatric Dermatology, held in Buenos Aires, Argentina from April 8–11, 2025, offered a valuable opportunity to hear from experts and gain insights and perspectives on the field. Here are some key takeaways.

Author Biography

Cathryn Sibbald, MSc, MD, FRCPC, DABD, Division of Dermatology, Department of Paediatrics The Hospital for Sick Children, Toronto, ON, University of Toronto, Toronto, ON

Dr. Sibbald is a dermatologist who completed her residency training at the University of Toronto and is board certified in Canada and the US. She completed fellowship training in pediatric dermatology at the Children’s Hospital of Philadelphia.  She has an MSc in Epidemiology from the London School of Hygiene & Tropical Medicine and a BSc PhM from the University of Toronto. She is a staff physician with research and clinical activities at the Hospital for Sick Children, and recently joined the pyoderma gangrenosum clinic at Women’s College Hospital. She is an assistant Professor at the University of Toronto in the Department of Pediatrics with a cross appointment to the Department of Medicine. Her clinical interests are broad and include alopecia, morphea, and laser treatment of vascular lesions.

References

Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, et al. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. Br J Dermatol. 2024 Jan 23;190(2):e13. doi: 10.1093/bjd/ljad442.] [published correction appears in Br J Dermatol. 2024 Jun 20;191(1):e1. doi: 10.1093/bjd/ljae157.] Br J Dermatol. 2023;189(6):674-684. doi:10.1093/bjd/ljad281

Kasap N, Kara A, Celik V, Bilgic Eltan S, Akay Haci I, Kose H, et al. Atypical localization of eczema discriminates DOCK8 or STAT3 deficiencies from atopic dermatitis. J Clin Immunol. 2023;43(8):1882-1890. doi:10.1007/s10875-023-01554-z

Huang JT, Coughlin CC, Hawryluk EB, Hook K, Humphrey SR, Kruse L, et al. Risk factors and outcomes of nonmelanoma skin cancer in children and young adults. J Pediatr. 2019;211:152-158. doi:10.1016/j.jpeds.2019.04.017

Takeichi T, Hsu CK, Yang HS, Chen HY, Wong TW, Tsai WL, et al. Progressive hyperpigmentation in a Taiwanese child due to an inborn error of vitamin B12 metabolism (cblJ). Br J Dermatol. 2015;172(4):1111-1115. doi:10.1111/bjd.13413

Gracci S, Novelli T, D’Elios S, Bernardini R, Peroni D. Hyper IgE syndromes. Curr Pediatr Rev. 2024;20(3):253-264. doi:10.2174/1573396320666230912103124

Atzmony L, Ugwu N, Hamilton C, Paller AS, Zech L, Antaya RJ, et al. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders. Pediatr Dermatol. 2022;39(6):903-907. doi:10.1111/pde.15094

IJspeert H, Edwards ESJ, O’Hehir RE, Dalm V, van Zelm MC. Update on inborn errors of immunity. J Allergy Clin Immunol. 2025;155(3):740-751. doi:10.1016/j.jaci.2024.12.1075

Zhang Z, Lu Y, Shi C, Chen M, He X, Zhang H. Pediatric dermatofibrosarcoma protuberans: a clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China. Front Oncol. 2023;13:1017154. doi:10.3389/fonc.2023.1017154

Fernandez ER, Tamura D, Khan SG, Momen S, Fassihi H, Sarkany R, et al. Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers. Front Oncol. 2023;13:1282823. doi:10.3389/fonc.2023.1282823

El Mansouri M, Essaddouki S, Mouradi M, Oukerroum A, El Fatoiki FZ, Truchuela MT, et al. Evaluation of the effectiveness and safety of combined oral and topical photoprotection with a standardized extract of Polypodium leucotomos (Fernblock(R)) in a Moroccan population with xeroderma pigmentosum. Photodermatol Photoimmunol Photomed. 2023;39(6):607-612. doi:10.1111/phpp.12904

Grootens-Wiegers P, Hein IM, van den Broek JM, de Vries MC. Medical decision-making in children and adolescents: developmental and neuroscientific aspects. BMC Pediatr. 2017;17(1):120. doi:10.1186/s12887-017-0869-x

Mazereeuw-Hautier J, Granier Tournier C, Hernandez-Martin A, Milesi S, Texier H, Severino-Freire M, et al. Biologics in congenital ichthyosis: are they effective? Br J Dermatol. 2025;192(2):327-334. doi:10.1093/bjd/ljae420

Nystrom A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, et al. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med. 2015;7(9):1211-1228. doi:10.15252/emmm.201505061

Kiritsi D, Schauer F, Gewert S, Reineker K, Reimer-Taschenbrecker A, Schwieger-Briel A, et al. Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial. EClinicalMedicine. 2024;77:102900. doi:10.1016/j.eclinm.2024.102900

Olaiwan A, Chandesris MO, Fraitag S, Lortholary O, Hermine O, Fischer A, et al. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol. 2011;65(6):1167-1172. doi:10.1016/j.jaad.2010.09.714

Agarwal S. Chronic granulomatous disease. J Clin Diagn Res. 2015;9(5):SD01-SD2. doi:10.7860/JCDR/2015/12139.5945

Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum. 2011;63(12):4018-4022. doi:10.1002/art.30565

Ellingford JM, Black GC, Clayton TH, Judge M, Griffiths CE, Warren RB. A novel mutation in IL36RN underpins childhood pustular dermatosis. J Eur Acad Dermatol Venereol. 2016;30(2):302-305. doi:10.1111/jdv.13034

Downloads

Published

2025-06-25

How to Cite

1.
Sibbald C. The World Congress of Pediatric Dermatology: Key Sessions and Takeaways. Can Dermatol Today [Internet]. 2025 Jun. 25 [cited 2025 Jun. 28];6(2):17–21. Available from: https://canadiandermatologytoday.com/article/view/6-1-Sibbald

Issue

Volume 6, Issue 2, Summer 2025

Section

Articles